Hepatitis C virus infection in patients with primary biliary cirrhosis
Journal Title: Annals of Hepatology - Year 2013, Vol 12, Issue 1
Abstract
[b]Background and aim[/b]. The aim of this study is to evaluate the role of hepatitis C virus (HCV) infection in patients with primary biliary cirrhosis (PBC). [b]Material and methods[/b]. On the basis of a retrospective review of medical records, all patients consecutively diagnosed with PBC or HCV infection between 1999 and 2011 and who had a regular follow-up of at least 3 years were included in the study. Clinical characteristics, especially the severity of cirrhosis, were analyzed in PBC patients with HCV infection (PBC-HCV), PBC patients without HCV infection (PBC-only), and patients with only HCV infection (HCV-only). [b]Results[/b]. A total of 76 patients with PBC, including 9 patients with HCV infection, were analyzed. Of the PBC-HCV patients, 7 (7/9, 77.8%) were women with a mean age of 55.11 ± 14.29 years. Age- and sex-matched PBC-only patients (n = 36) and HCV-only patients (n = 36) were used as control groups. In comparison to the PBC-only controls, PBC-HCV patients had a greater severity of cirrhosis based on Child-Pugh (p = 0.019) and Model for End-Stage Liver Disease (MELD) (p = 0.01) scores. However, no significant difference in the severity of cirrhosis was found between the PBC-HCV and HCV-only control patients (p = 0.94 in Child-Pugh scores; p = 0.64 in MELD scores). [b]Conclusions[/b]. In PBC patients with concomitant HCV infection, aggressive managementmay be warranted in view of the associated more severe liver cirrhosis.
Authors and Affiliations
Chen Hsuan-Wei, Huang Hsin-Hung, Lai Ching-Huang, Chang Wei-En, Shih Yu-Lueng, Hsieh Tsai-Yuan, Chu Heng-Cheng
Keywords
Related Articles
- EP ID EP78234
- DOI -
- Views 106
- Downloads 0
Most overweight and obese Indian children have nonalcoholic fatty liver disease
Background and rationale. Nonalcoholic fatty liver disease (NAFLD) is the most common cause of pediatric liver disease in western countries. Its prevalence in Indian subcontinent is not well studied. Material and method...
The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem
Background and aim. In the fall of 2013, the US Centers for Disease Control and Prevention (CDC) published a preliminary report on a cluster of liver disease cases that emerged in Hawaii in the summer 2013. This report c...
Severe hypercholesterolemia mediated by lipoprotein X in a patient with cholestasis
Lipoprotein X (LpX) is an abnormal lipoprotein associated with cholestasis. It is a significant cause of severe hypercholesterolemia and should always be considered in patients with cholestatic liver disease. This case h...
Gut microbiota and nonalcoholic fatty liver disease
Recent evidence has linked obesity and the metabolic syndrome with gut dysbiota. The precise mechanisms underlying that association are not entirely understood; however, microbiota can enhance the extraction of energy f...
Meta-analysis of prophylactic entecavir or lamivudine against hepatitis B virus reactivation
Introduction and aim. Studies suggest that entecavir and lamivudine are useful as prophylactics against hepatitis B virus (HBV) reactivation in patients undergoing chemotherapy or immunosuppressive therapy, but which dr...